Resveratrol Prevents Right Ventricle Remodeling and Dysfunction in Monocrotaline-Induced Pulmonary Arterial Hypertension with a Limited Improvement in the Lung Vasculature

Pulmonary arterial hypertension (PAH) is a life-threatening disease that is characterized by an increase in pulmonary vascular pressure, leading to ventricular failure and high morbidity and mortality. Resveratrol, a phenolic compound and a sirtuin 1 pathway activator, has known dietary benefits and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vázquez-Garza, Eduardo, Bernal-Ramírez, Judith, Jerjes-Sánchez, Carlos, Lozano, Omar, Acuña-Morín, Edgar, Vanoye-Tamez, Mariana, Ramos-González, Martín R., Chapoy-Villanueva, Héctor, Pérez-Plata, Luis, Sánchez-Trujillo, Luis, Torre-Amione, Guillermo, Ramírez-Rivera, Alicia, García-Rivas, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023844/
https://www.ncbi.nlm.nih.gov/pubmed/32089765
http://dx.doi.org/10.1155/2020/1841527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023844/
https://www.ncbi.nlm.nih.gov/pubmed/32089765
http://dx.doi.org/10.1155/2020/1841527

Ejemplares similares